Competitors cannot have used any substances listed below during the duration periods specified. All participants are required to pass polygraph screenings prior to competitions (polygraph test results from amateur OCB and other amateur natural federations’ shows can be honored for amateur OCB shows held within six weeks from the contest where testing took place). For federations other than OCB, the polygraph examiner who conducted the testing must send verification to OCB, or the examiner’s name and contact information must be supplied to OCB in order for results to be honored). In addition to polygraph testing, pro qualifying placement winners at amateur events, and the top three placement winners in pro classes at pro events, must pass a urine test.
Polygraphscreenings are used since events are 7 years drug-free for most substances. Most anabolic steroids and other banned substances are no longer detectable in urine within a couple of months from last use, and growth hormone use cannot be detected with urine testing. Note: Approximately half who don’t pass the polygraph are bikini competitors. Certain banned substances can yield an unfair advantage in getting leaner and shapelier.
ANABOLIC STEROIDS AND AGENTS (INCLUDING METABOLITES) – BANNED 7 YEARS
Including, but not limited to (some trade names shown in parenthesis):
DHEA in excess of 100mg/day (aka androstenolone)
SARMs (selective androgen receptor modulators) (after 12/31/15)
PRESCRIPTION-GRADE STIMULANTS AND WEIGHT-LOSS SUBSTANCES – BANNED 6 MONTHS
Including, but not limited to:
PRESCRIPTION-GRADE DIURETICS USED FOR COMPETITION PURPOSES – BANNED 1 WEEK
Including, but not limited to:
Hydrochlorothiazide (aka HCT or HCTZ)
Use of growth hormones, prescription-grade anti-estrogens (including, but not limited to, Arimidex, Clomid, Nolvadex, and HCG), Clenbuterol, masking agents, and Synthol is disallowed for a period of 7 years prior to participation in an OCB event.
Urine test lab reports showing only a testosterone/epitestosterone (T/E) ratio above 6.0 are considered positive results for presence of banned substances and result in disqualification with a 7-year suspension, unless competitors exercise the option of having isotope ratio mass spectrometry (IRMS) analyses performed on their sample at their own expense ($450), and those results show no synthetic testosterone was detected.
Any athletes with muscle implants are considered ineligible for OCB events indefinitely.
POLICY ON PRESCRIBED TESTOSTERONE
OCB handles theraputic use exemptions for prescribed testosterone due to androgen deficiency in the manner that the World Anti-Doping Agency (WADA) does.
Exemptions are possible in cases where there’s a pathological physical change in the structure of an organ or within the hypothalamic-pituitary-testicular axis, such as:
Genetic abnormalities – Isolated hypogonadotropic hypogonadism (IHH) and variants, Klinefelter’s Syndrome and variants (i.e. 47,XYY/46XY, 46,XX testicular DSD, 45,X/46,XY), dysgenetic testes, myotonic dystrophy.
Developmental abnormalities – cryptorchidism, congenital anorchia.
Metabolic abnormalities – hemochromatosis.
Direct testicular trauma, surgical bilateral orchidectomy, testicular torsion.
Orchitis – severe bilateral with subsequent testicular atrophy due to mumps or other infections.
Radiation treatment or chemotherapy.
Pituitary disorders – hypopituitarism, tumor, infection, hemochromatosis, hyperprolactinemia due to prolactin-secreting pituitary tumor.
Structural and infiltrative effects of systemic diseases – CNS developmental abnormalities, infection, β-thalassemia/hemoglobinopathies, granulomatous diseases, lymphocytic hypophysitis hemochromatosis, sickle cell disease.
Anatomical problems – pituitary stalk section, hypophysectomy, pituitary-hypothalamic disease, traumatic brain injury.
Exemptions are not made in cases where there is no pathological physical change in the structure of an organ or within the hypothalamic-pituitary-testicular axis, such as:
Overtraining, malnutrition/nutritional deficiency.
Chronic systemic illness (chronic organ failure, diabetes mellitus, malignancy, rheumatic disease, HIV infection, Crohn’s disease, inherited metabolic storage diseases).
Aging/Late onset hypogonadism.